Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Free radical-mediated damage to brain in Alzheimer s disease and its transgenic mouse models Sonnen JA; Breitner JC; Lovell MA; Markesbery WR; Quinn JF; Montine TJFree Radic Biol Med 2008[Aug]; 45 (3): 219-30Advances in our understanding of the etiologies and pathogenesis of Alzheimer's disease (AD) highlight a role for free radical-mediated injury to brain regions from early stages of this illness. Here we will review the evidence from transgenic mouse models of AD, autopsy samples, and human biofluids obtained during life paying particular attention to the stage of disease. In addition, we will review the epidemiologic literature that addresses the potential of anti-oxidants to prevent incident dementia from AD, and the clinical trial literature that addresses anti-oxidant preventative or therapeutic strategies for different stage of AD. Future efforts in preclinical models and ultimately clinical trials are needed to define optimally effective agents and combinations, doses, and timing to suppress safely this facet of AD.|Alzheimer Disease/drug therapy/*etiology/pathology[MESH]|Animals[MESH]|Antioxidants/therapeutic use[MESH]|Brain/*pathology[MESH]|Clinical Trials as Topic[MESH]|Free Radicals/*toxicity[MESH]|Humans[MESH]|Mice[MESH]|Mice, Transgenic[MESH] |